Modeling individual variability in CD19 CAR-T therapy: An in vivo study with PBMC-humanized mice

被引：0
|
作者：
Lee, Won
Rose, Destanie
Keck, James G.
Yang, Jiwon
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3850
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3850
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Assessing Individual Variability in Autologous CD19 CAR T Therapy with PBMC-Humanized Mice
    Lee, Won
    Rose, Destanie
    Keck, James
    Yang, Jiwon
    MOLECULAR THERAPY, 2024, 32 (04) : 631 - 631
  • [2] Assessing impacts of tumor burden and CAR-T cell dosage on the toxicity and efficacy profile of CD19 CAR-T therapy in a PBMC-humanized mouse model
    Lee, Won
    Rose, Destanie
    Keck, James G.
    Yang, Jiwon
    CANCER RESEARCH, 2024, 84 (06)
  • [3] PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Universal CD19 Chimeric Antigen Receptor T Cell Immunotherapy
    Lee, Won
    Rose, Destanie
    Gustafson, Heather
    Jackson, Meredith
    Gwiazda, Kamila
    Gustafson, Joshua
    Ott, Mariliis
    Gardner, Rebecca
    Keck, James G.
    Yang, Jiwon
    BLOOD, 2023, 142
  • [4] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [5] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [6] Quantification of ADA of Humanized CD19 CAR-T Cell Therapy in R/R LBCL
    Huang, Zhongpei
    Mei, Heng
    Li, Chenggong
    Hu, Yu
    BLOOD, 2023, 142
  • [7] CD19 CAR-T therapy and sepsis: dancing with the devil
    Budde, Lihua E.
    Zaia, John A.
    BLOOD, 2018, 131 (01) : 7 - 8
  • [8] Modelling CAR-T therapy in humanized mice
    Wu, Yongxia
    Yu, Xue-Zhong
    EBIOMEDICINE, 2019, 40 : 25 - 26
  • [9] Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy
    Zhao, Yu
    Zhang, Jianping
    Yang, Junfang
    Wu, Huantong
    Chen, Yao
    Li, Nannan
    Liu, Zhongfeng
    Wang, Xuan
    Liu, Weihua
    Zhang, Guangji
    Zhou, Bin-Bing Stephen
    Lu, Peihua
    Chen, Zhiguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Toxicities of CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Turtle, Cameron J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S42 - S49
12345